QT
DNA icon

Quantbot Technologies’s Ginkgo Bioworks DNA Stock Holding History

Quantbot Technologies’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3K Sell
2,012
-388
-16% -$3.23K ﹤0.01% 1517
2025
Q4 		$19.9K Buy
+2,400
New +$25.8K ﹤0.01% 1567
2025
Q3 		– Sell
-1,004
Closed -$11.3K – 1815
2025
Q2 		$11.3K Buy
+1,004
New +$7.78K ﹤0.01% 1551
2023
Q2 		– Sell
-1,322
Closed -$70.3K – 1657
2023
Q1 		$70.3K Sell
1,322
-4,618
-78% -$293K 0.01% 1183
2022
Q4 		$402K Buy
+5,940
New +$546K 0.03% 654
2022
Q2 		– Sell
-38
Closed -$6K – 1787
2022
Q1 		$6K Sell
38
-10
-21% -$1.95K ﹤0.01% 1511
2021
Q4 		$15K Buy
+48
New +$22.8K ﹤0.01% 1256

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return